{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:10Z","timestamp":1790674090875,"version":"4.1.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"48","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,11,30]]},"DOI":"10.1038\/onc.2017.292","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T15:00:57Z","timestamp":1503327657000},"page":"6659-6667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pathways from senescence to melanoma: focus on MITF sumoylation"],"prefix":"10.1038","volume":"36","author":[{"given":"J","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ballotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"BFonc2017292_CR1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","volume":"485","author":"MF Berger","year":"2012","unstructured":"Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012; 485: 502\u2013506.","journal-title":"Nature"},{"key":"BFonc2017292_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251\u2013263.","journal-title":"Cell"},{"key":"BFonc2017292_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.3361","volume":"47","author":"M Krauthammer","year":"2015","unstructured":"Krauthammer M, Kong Y, Bacchiocchi A, Evans P, Pornputtapong N, Wu C et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas. Nat Genet 2015; 47: 996\u20131002.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006\u20131014.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Network TCGA","year":"2015","unstructured":"Network TCGA. Genomic classification of cutaneous melanoma. Cell 2015; 161: 1681\u20131696.","journal-title":"Cell"},{"key":"BFonc2017292_CR6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949\u2013954.","journal-title":"Nature"},{"key":"BFonc2017292_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1535-6108(02)00089-2","volume":"2","author":"PM Pollock","year":"2002","unstructured":"Pollock PM, Meltzer PS . A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2002; 2: 5\u20137.","journal-title":"Cancer Cell"},{"key":"BFonc2017292_CR8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6604637","volume":"99","author":"MA Davies","year":"2008","unstructured":"Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG et al. A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 2008; 99: 1265\u20131268.","journal-title":"Br J Cancer"},{"key":"BFonc2017292_CR9","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1206451","volume":"22","author":"H Wu","year":"2003","unstructured":"Wu H, Goel V, Haluska FG . PTEN signaling pathways in melanoma. Oncogene 2003; 22: 3113\u20133122.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2741\/1831","volume":"11","author":"L Larue","year":"2006","unstructured":"Larue L, Delmas V . The WNT\/Beta-catenin pathway in melanoma. Front Biosci 2006; 11: 733\u2013742.","journal-title":"Front Biosci"},{"key":"BFonc2017292_CR11","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.275.5307.1790","volume":"275","author":"B Rubinfeld","year":"1997","unstructured":"Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P . Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790\u20131792.","journal-title":"Science"},{"key":"BFonc2017292_CR12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1073\/pnas.1220895110","volume":"110","author":"MJ Davis","year":"2013","unstructured":"Davis MJ, Ha BH, Holman EC, Halaban R, Schlessinger J, Boggon TJ . RAC1P29S is a spontaneously activating cancer-associated GTPase. Proc Natl Acad Sci USA 2013; 110: 912\u2013917.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017292_CR13","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/jid.2012.186","volume":"132","author":"A Li","year":"2012","unstructured":"Li A, Ma Y, Jin M, Mason S, Mort RL, Blyth K et al. Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism. J Invest Dermatol 2012; 132: 2610\u20132621.","journal-title":"J Invest Dermatol"},{"key":"BFonc2017292_CR14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/pcmr.12004","volume":"25","author":"LM Machesky","year":"2012","unstructured":"Machesky LM, Sansom OJ . Rac1 in the driver's seat for melanoma. Pigment Cell Melanoma Res 2012; 25: 762\u2013764.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR15","doi-asserted-by":"crossref","first-page":"H2169","DOI":"10.1152\/ajpheart.00970.2010","volume":"300","author":"Y Xue","year":"2011","unstructured":"Xue Y, Li NL, Yang JY, Chen Y, Yang LL, Liu WC . Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression. Am J Physiol Heart Circ Physiol 2011; 300: H2169\u2013H2176.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFonc2017292_CR16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/ng.3427","volume":"47","author":"R Arafeh","year":"2015","unstructured":"Arafeh R, Qutob N, Emmanuel R, Keren-Paz A, Madore J, Elkahloun A et al. Recurrent inactivating RASA2 mutations in melanoma. Nat Genet 2015; 47: 1408\u20131410.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas N","year":"2015","unstructured":"Cancer Genome Atlas N. Genomic classification of cutaneous melanoma. Cell 2015; 161: 1681\u20131696.","journal-title":"Cell"},{"key":"BFonc2017292_CR18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1101\/gad.296962.117","volume":"31","author":"C Pandiani","year":"2017","unstructured":"Pandiani C, Beranger GE, Leclerc J, Ballotti R, Bertolotto C . Focus on cutaneous and uveal melanoma specificities. Genes Dev 2017; 31: 724\u2013743.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.celrep.2013.08.023","volume":"4","author":"J Villanueva","year":"2013","unstructured":"Villanueva J, Infante JR, Krepler C, Reyes-Uribe P, Samanta M, Chen HY et al. Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma. Cell reports 2013; 4: 1090\u20131099.","journal-title":"Cell reports"},{"key":"BFonc2017292_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33: 19\u201320.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.jid.5700490","volume":"127","author":"J Bauer","year":"2007","unstructured":"Bauer J, Curtin JA, Pinkel D, Bastian BC . Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 2007; 127: 179\u2013182.","journal-title":"J Invest Dermatol"},{"key":"BFonc2017292_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","volume":"157","author":"BC Bastian","year":"2000","unstructured":"Bastian BC, LeBoit PE, Pinkel D . Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967\u2013972.","journal-title":"Am J Pathol"},{"key":"BFonc2017292_CR23","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1101\/gad.1971610","volume":"24","author":"T Kuilman","year":"2010","unstructured":"Kuilman T, Michaloglou C, Mooi WJ, Peeper DS . The essence of senescence. Genes Dev 2010; 24: 2463\u20132479.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","volume":"95","author":"VC Gray-Schopfer","year":"2006","unstructured":"Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 2006; 95: 496\u2013505.","journal-title":"Br J Cancer"},{"key":"BFonc2017292_CR25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/pcmr.12060","volume":"26","author":"AD Mackenzie Ross","year":"2013","unstructured":"Mackenzie Ross AD, Cook MG, Chong H, Hossain M, Pandha HS, Bennett DC . Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression. Pigment Cell Melanoma Res 2013; 26: 226\u2013235.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.18632\/aging.100537","volume":"5","author":"S Tran","year":"2013","unstructured":"Tran S, Rizos H . Human nevi lack distinguishing senescence traits. Aging 2013; 5: 98\u201399.","journal-title":"Aging"},{"key":"BFonc2017292_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-62703-239-1_21","volume":"965","author":"SL Tran","year":"2013","unstructured":"Tran SL, Rizos H . Monitoring oncogenic B-RAF-induced senescence in melanocytes. Methods Mol Biol 2013; 965: 313\u2013326.","journal-title":"Methods Mol Biol"},{"key":"BFonc2017292_CR28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436: 720\u2013724.","journal-title":"Nature"},{"key":"BFonc2017292_CR29","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1038\/onc.2008.258","volume":"27","author":"D Zhuang","year":"2008","unstructured":"Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA et al. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 2008; 27: 6623\u20136634.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ncb1471","volume":"8","author":"C Denoyelle","year":"2006","unstructured":"Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006; 8: 1053\u20131063.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017292_CR31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pcmr.12369","volume":"28","author":"L Larribere","year":"2015","unstructured":"Larribere L, Wu H, Novak D, Galach M, Bernhardt M, Orouji E et al. NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. Pigment Cell Melanoma Res 2015; 28: 407\u2013416.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.18632\/aging.100051","volume":"1","author":"S Haferkamp","year":"2009","unstructured":"Haferkamp S, Tran SL, Becker TM, Scurr LL, Kefford RF, Rizos H . The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging 2009; 1: 542\u2013556.","journal-title":"Aging"},{"key":"BFonc2017292_CR33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.187252.112","volume":"26","author":"LC Vredeveld","year":"2012","unstructured":"Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev 2012; 26: 1055\u20131069.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR34","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1158\/2159-8290.CD-15-0196","volume":"5","author":"AS McNeal","year":"2015","unstructured":"McNeal AS, Liu K, Nakhate V, Natale CA, Duperret EK, Capell BC et al. CDKN2B loss promotes progression from benign melanocytic nevus to melanoma. Cancer Discov 2015; 5: 1072\u20131085.","journal-title":"Cancer Discov"},{"key":"BFonc2017292_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","volume":"132","author":"N Wajapeyee","year":"2008","unstructured":"Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR . Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132: 363\u2013374.","journal-title":"Cell"},{"key":"BFonc2017292_CR36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cell.2010.04.021","volume":"141","author":"LL Scurr","year":"2010","unstructured":"Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S et al. IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell 2010; 141: 717\u2013727.","journal-title":"Cell"},{"key":"BFonc2017292_CR37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133: 1019\u20131031.","journal-title":"Cell"},{"key":"BFonc2017292_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc2560","volume":"9","author":"T Kuilman","year":"2009","unstructured":"Kuilman T, Peeper DS . Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81\u201394.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017292_CR39","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/onc.2009.95","volume":"28","author":"VK Goel","year":"2009","unstructured":"Goel VK, Ibrahim N, Jiang G, Singhal M, Fee S, Flotte T et al. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene 2009; 28: 2289\u20132298.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","volume":"15","author":"EE Patton","year":"2005","unstructured":"Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005; 15: 249\u2013254.","journal-title":"Curr Biol"},{"key":"BFonc2017292_CR41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr. et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 2009; 41: 544\u2013552.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","volume":"15","author":"N Dhomen","year":"2009","unstructured":"Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 2009; 15: 294\u2013303.","journal-title":"Cancer Cell"},{"key":"BFonc2017292_CR43","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F . Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res 2005; 65: 4005\u20134011.","journal-title":"Cancer Res"},{"key":"BFonc2017292_CR44","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.4161\/cc.6.19.4754","volume":"6","author":"J Bartek","year":"2007","unstructured":"Bartek J, Lukas J, Bartkova J . DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle 2007; 6: 2344\u20132347.","journal-title":"Cell Cycle"},{"key":"BFonc2017292_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638\u2013642.","journal-title":"Nature"},{"key":"BFonc2017292_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/gad.1487307","volume":"21","author":"FA Mallette","year":"2007","unstructured":"Mallette FA, Gaumont-Leclerc MF, Ferbeyre G . The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21: 43\u201348.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR47","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ncb1911","volume":"11","author":"P Abdallah","year":"2009","unstructured":"Abdallah P, Luciano P, Runge KW, Lisby M, Geli V, Gilson E et al. A two-step model for senescence triggered by a single critically short telomere. Nat Cell Biol 2009; 11: 988\u2013993.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017292_CR48","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1055-9965.EPI-07-0152","volume":"16","author":"V Bataille","year":"2007","unstructured":"Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, Lens M et al. Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 2007; 16: 1499\u20131502.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc2017292_CR49","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/emboj.2012.132","volume":"31","author":"A Suram","year":"2012","unstructured":"Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 2012; 31: 2839\u20132851.","journal-title":"EMBO J"},{"key":"BFonc2017292_CR50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000372-200302000-00019","volume":"25","author":"BC Bastian","year":"2003","unstructured":"Bastian BC . The longer your telomeres, the larger your nevus? Am J Dermatopathol 2003; 25: 83\u201384.","journal-title":"Am J Dermatopathol"},{"key":"BFonc2017292_CR51","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/pcmr.12422","volume":"29","author":"DC Bennett","year":"2016","unstructured":"Bennett DC . Genetics of melanoma progression: the rise and fall of cell senescence. Pigment Cell Melanoma Res 2016; 29: 122\u2013140.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian BC . The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 2014; 9: 239\u2013271.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2017292_CR53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.biocel.2004.10.013","volume":"37","author":"I Ben-Porath","year":"2005","unstructured":"Ben-Porath I, Weinberg RA . The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37: 961\u2013976.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc2017292_CR54","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrc929","volume":"2","author":"AA Neumann","year":"2002","unstructured":"Neumann AA, Reddel RR . Telomere maintenance and cancer\u2014look, no telomerase. Nat Rev Cancer 2002; 2: 879\u2013884.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017292_CR55","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1038\/ncomms9093","volume":"6","author":"A Conde-Perez","year":"2015","unstructured":"Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z et al. A caveolin-dependent and PI3K\/AKT-independent role of PTEN in beta-catenin transcriptional activity. Nat Commun 2015; 6: 8093.","journal-title":"Nat Commun"},{"key":"BFonc2017292_CR56","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1101\/gad.450107","volume":"21","author":"V Delmas","year":"2007","unstructured":"Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 2007; 21: 2923\u20132935.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1474-9726.2008.00422.x","volume":"7","author":"S Haferkamp","year":"2008","unstructured":"Haferkamp S, Becker TM, Scurr LL, Kefford RF, Rizos H . p16INK4a-induced senescence is disabled by melanoma-associated mutations. Aging Cell 2008; 7: 733\u2013745.","journal-title":"Aging Cell"},{"key":"BFonc2017292_CR58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature13298","volume":"511","author":"A Viros","year":"2014","unstructured":"Viros A, Sanchez-Laorden B, Pedersen M, Furney SJ, Rae J, Hogan K et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature 2014; 511: 478\u2013482.","journal-title":"Nature"},{"key":"BFonc2017292_CR59","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1073\/pnas.0909292106","volume":"106","author":"S Zhu","year":"2009","unstructured":"Zhu S, Wurdak H, Wang Y, Galkin A, Tao H, Li J et al. A genomic screen identifies TYRO3 as a MITF regulator in melanoma. Proc Natl Acad Sci USA 2009; 106: 17025\u201317030.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017292_CR60","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/onc.2011.339","volume":"31","author":"S Mannava","year":"2012","unstructured":"Mannava S, Omilian AR, Wawrzyniak JA, Fink EE, Zhuang D, Miecznikowski JC et al. PP2A-B56alpha controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene 2012; 31: 1484\u20131492.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR61","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","volume":"69","author":"NF Box","year":"2001","unstructured":"Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001; 69: 765\u2013773.","journal-title":"Am J Hum Genet"},{"key":"BFonc2017292_CR62","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/jnci\/djq363","volume":"102","author":"F Demenais","year":"2010","unstructured":"Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT et al. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst 2010; 102: 1568\u20131583.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2017292_CR63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","volume":"28","author":"LG Aoude","year":"2015","unstructured":"Aoude LG, Wadt KA, Pritchard AL, Hayward NK . Genetics of familial melanoma: 20 years after CDKN2A. Pigment Cell Melanoma Res 2015; 28: 148\u2013160.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng0795-351","volume":"10","author":"NA Gruis","year":"1995","unstructured":"Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995; 10: 351\u2013353.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR65","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","volume":"20","author":"H Rizos","year":"2001","unstructured":"Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jimenez L et al. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 2001; 20: 5543\u20135547.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","volume":"6","author":"CJ Sherr","year":"2016","unstructured":"Sherr CJ, Beach D, Shapiro GI . Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov 2016; 6: 353\u2013367.","journal-title":"Cancer Discov"},{"key":"BFonc2017292_CR67","doi-asserted-by":"crossref","first-page":"a026302","DOI":"10.1101\/cshperspect.a026302","volume":"6","author":"S Basu","year":"2016","unstructured":"Basu S, Murphy ME . Genetic Modifiers of the p53 Pathway. Cold Spring Harb Perspect Med 2016; 6: a026302.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFonc2017292_CR68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996; 12: 97\u201399.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR69","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","volume":"95","author":"EV Sviderskaya","year":"2003","unstructured":"Sviderskaya EV, Gray-Schopfer VC, Hill SP, Smit NP, Evans-Whipp TJ, Bond J et al. p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J Natl Cancer Inst 2003; 95: 723\u2013732.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2017292_CR70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/94.6.446","volume":"94","author":"EV Sviderskaya","year":"2002","unstructured":"Sviderskaya EV, Hill SP, Evans-Whipp TJ, Chin L, Orlow SJ, Easty DJ et al. p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst 2002; 94: 446\u2013454.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2017292_CR71","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1073\/pnas.0611638104","volume":"104","author":"L Ha","year":"2007","unstructured":"Ha L, Ichikawa T, Anver M, Dickins R, Lowe S, Sharpless NE et al. ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci USA 2007; 104: 10968\u201310973.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017292_CR72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F . The RB and p53 pathways in cancer. Cancer Cell 2002; 2: 103\u2013112.","journal-title":"Cancer Cell"},{"key":"BFonc2017292_CR73","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12062","volume":"26","author":"C Fung","year":"2013","unstructured":"Fung C, Pupo GM, Scolyer RA, Kefford RF, Rizos H . p16(INK) (4a) deficiency promotes DNA hyper-replication and genetic instability in melanocytes. Pigment Cell Melanoma Res 2013; 26: 236\u2013246.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR74","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1755-148X.2010.00773.x","volume":"23","author":"T Terzian","year":"2010","unstructured":"Terzian T, Torchia EC, Dai D, Robinson SE, Murao K, Stiegmann RA et al. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell Melanoma Res 2010; 23: 781\u2013794.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR75","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1038\/ncomms6348","volume":"5","author":"C Christensen","year":"2014","unstructured":"Christensen C, Bartkova J, Mistrik M, Hall A, Lange MK, Ralfkiaer U et al. A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility. Nat Commun 2014; 5: 5348.","journal-title":"Nat Commun"},{"key":"BFonc2017292_CR76","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/11.11.1273","volume":"11","author":"C Hewitt","year":"2002","unstructured":"Hewitt C, Lee WuC, Evans G, Howell A, Elles RG, Jordan R et al. Germline mutation of ARF in a melanoma kindred. Hum Mol Genet 2002; 11: 1273\u20131279.","journal-title":"Hum Mol Genet"},{"key":"BFonc2017292_CR77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejcb.2013.11.005","volume":"93","author":"S Meierjohann","year":"2014","unstructured":"Meierjohann S . Oxidative stress in melanocyte senescence and melanoma transformation. Eur J Cell Biol 2014; 93: 36\u201341.","journal-title":"Eur J Cell Biol"},{"key":"BFonc2017292_CR78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/msb.2010.5","volume":"6","author":"JF Passos","year":"2010","unstructured":"Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 2010; 6: 347.","journal-title":"Mol Syst Biol"},{"key":"BFonc2017292_CR79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G . BAP1 and cancer. Nat Rev Cancer 2013; 13: 153\u2013159.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017292_CR80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1541-7786.MCR-14-0305","volume":"13","author":"CD Robles-Espinoza","year":"2015","unstructured":"Robles-Espinoza CD, Velasco-Herrera Mdel C, Hayward NK, Adams DJ . Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res 2015; 13: 211\u2013222.","journal-title":"Mol Cancer Res"},{"key":"BFonc2017292_CR81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","volume":"480","author":"C Bertolotto","year":"2011","unstructured":"Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011; 480: 94\u201398.","journal-title":"Nature"},{"key":"BFonc2017292_CR82","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12047","volume":"26","author":"P Ghiorzo","year":"2013","unstructured":"Ghiorzo P, Pastorino L, Queirolo P, Bruno W, Tibiletti MG, Nasti S et al. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res 2013; 26: 259\u2013262.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR83","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jid.2013.272","volume":"134","author":"RA Sturm","year":"2014","unstructured":"Sturm RA, Fox C, McClenahan P, Jagirdar K, Ibarrola-Villava M, Banan P et al. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients. J Invest Dermatol 2014; 134: 141\u2013149.","journal-title":"J Invest Dermatol"},{"key":"BFonc2017292_CR84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011; 480: 99\u2013103.","journal-title":"Nature"},{"key":"BFonc2017292_CR85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1083\/jcb.142.3.827","volume":"142","author":"C Bertolotto","year":"1998","unstructured":"Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998; 142: 827\u2013835.","journal-title":"J Cell Biol"},{"key":"BFonc2017292_CR86","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","volume":"11","author":"P Valverde","year":"1995","unstructured":"Valverde P, Healy E, Jackson I, Rees JL, Thody AJ . Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11: 328\u2013330.","journal-title":"Nat Genet"},{"key":"BFonc2017292_CR87","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1038\/jid.2015.280","volume":"135","author":"SG Jarrett","year":"2015","unstructured":"Jarrett SG, Wolf Horrell EM, Boulanger MC, D'Orazio JA . Defining the contribution of MC1R physiological ligands to ATR phosphorylation at Ser435, a predictor of DNA repair in melanocytes. J Invest Dermatol 2015; 135: 3086\u20133095.","journal-title":"J Invest Dermatol"},{"key":"BFonc2017292_CR88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/pcmr.12252","volume":"27","author":"V Swope","year":"2014","unstructured":"Swope V, Alexander C, Starner R, Schwemberger S, Babcock G, Abdel-Malek ZA . Significance of the melanocortin 1 receptor in the DNA damage response of human melanocytes to ultraviolet radiation. Pigment Cell Melanoma Res 2014; 27: 601\u2013610.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR89","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2013.08.010","volume":"51","author":"J Cao","year":"2013","unstructured":"Cao J, Wan L, Hacker E, Dai X, Lenna S, Jimenez-Cervantes C et al. MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol Cell 2013; 51: 409\u2013422.","journal-title":"Mol Cell"},{"key":"BFonc2017292_CR90","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.genet.38.072902.092717","volume":"38","author":"E Steingrimsson","year":"2004","unstructured":"Steingrimsson E, Copeland NG, Jenkins NA . Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 2004; 38: 365\u2013411.","journal-title":"Annu Rev Genet"},{"key":"BFonc2017292_CR91","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/MCB.18.2.694","volume":"18","author":"C Bertolotto","year":"1998","unstructured":"Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 1998; 18: 694\u2013702.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017292_CR92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","volume":"23","author":"Y Cheli","year":"2010","unstructured":"Cheli Y, Ohanna M, Ballotti R, Bertolotto C . Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res 2010; 23: 27\u201340.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFonc2017292_CR93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","volume":"436","author":"LA Garraway","year":"2005","unstructured":"Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436: 117\u2013122.","journal-title":"Nature"},{"key":"BFonc2017292_CR94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature12688","volume":"504","author":"CM Johannessen","year":"2013","unstructured":"Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 2013; 504: 138\u2013142.","journal-title":"Nature"},{"key":"BFonc2017292_CR95","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/2159-8290.CD-13-0424","volume":"4","author":"DJ Konieczkowski","year":"2014","unstructured":"Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA, Piris A et al. A melanoma cell state distinction lnfluences sensitivity to MAPK pathway inhibitors. Cancer Discov 2014; 4: 816\u2013827.","journal-title":"Cancer Discov"},{"key":"BFonc2017292_CR96","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","volume":"5","author":"J Muller","year":"2014","unstructured":"Muller J, Krijgsman O, Tsoi J, Robert L, Hugo W, Song C et al. Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat Commun 2014; 5: 5712.","journal-title":"Nat Commun"},{"key":"BFonc2017292_CR97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","volume":"4","author":"EM Van Allen","year":"2013","unstructured":"Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov 2013; 4: 94\u2013109.","journal-title":"Cancer Discov"},{"key":"BFonc2017292_CR98","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1101\/gad.290940.116","volume":"31","author":"P Falletta","year":"2017","unstructured":"Falletta P, Sanchez-Del-Campo L, Chauhan J, Effern M, Kenyon A, Kershaw CJ et al. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev 2017; 31: 18\u201333.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR99","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1038\/ncomms9755","volume":"6","author":"S Riesenberg","year":"2015","unstructured":"Riesenberg S, Groetchen A, Siddaway R, Bald T, Reinhardt J, Smorra D et al. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nat Commun 2015; 6: 8755.","journal-title":"Nat Commun"},{"key":"BFonc2017292_CR100","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","volume":"20","author":"S Carreira","year":"2006","unstructured":"Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 2006; 20: 3426\u20133439.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamadermatol.2015.4356","volume":"152","author":"M Potrony","year":"2016","unstructured":"Potrony M, Puig-Butille JA, Aguilera P, Badenas C, Tell-Marti G, Carrera C et al. Prevalence of MITF p.E318K in patients with melanoma independent of the presence of CDKN2A causative mutations. JAMA Dermatol 2016; 152: 405\u2013412.","journal-title":"JAMA Dermatol"},{"key":"BFonc2017292_CR102","doi-asserted-by":"crossref","unstructured":"Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M et al. Deciphering the role of oncogenic MITFE318K in senescence delay and melanoma progression. J Natl Cancer Inst 2017; 109 doi:10.1093\/jnci\/djw340.","DOI":"10.1093\/jnci\/djw340"},{"key":"BFonc2017292_CR103","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1074\/jbc.M411757200","volume":"280","author":"AJ Miller","year":"2005","unstructured":"Miller AJ, Levy C, Davis IJ, Razin E, Fisher DE . Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem 2005; 280: 146\u2013155.","journal-title":"J Biol Chem"},{"key":"BFonc2017292_CR104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0749.2005.00234.x","volume":"18","author":"H Murakami","year":"2005","unstructured":"Murakami H, Arnheiter H . Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res 2005; 18: 265\u2013277.","journal-title":"Pigment Cell Res"},{"key":"BFonc2017292_CR105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20100158","volume":"428","author":"KA Wilkinson","year":"2010","unstructured":"Wilkinson KA, Henley JM . Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 2010; 428: 133\u2013145.","journal-title":"Biochem J"},{"key":"BFonc2017292_CR106","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrm3011","volume":"11","author":"JR Gareau","year":"2010","unstructured":"Gareau JR, Lima CD . The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 2010; 11: 861\u2013871.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2017292_CR107","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1128\/MCB.23.24.9073-9080.2003","volume":"23","author":"C Levy","year":"2003","unstructured":"Levy C, Sonnenblick A, Razin E . Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol Cell Biol 2003; 23: 9073\u20139080.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017292_CR108","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1128\/MCB.24.24.10584-10592.2004","volume":"24","author":"A Sonnenblick","year":"2004","unstructured":"Sonnenblick A, Levy C, Razin E . Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol 2004; 24: 10584\u201310592.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017292_CR109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200712124","volume":"182","author":"YQ Zhang","year":"2008","unstructured":"Zhang YQ, Sarge KD . Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies. J Cell Biol 2008; 182: 35\u201339.","journal-title":"J Cell Biol"},{"key":"BFonc2017292_CR110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(10)06004-5","volume":"106","author":"JC Walrath","year":"2010","unstructured":"Walrath JC, Hawes JJ, Van Dyke T, Reilly KM . Genetically engineered mouse models in cancer research. Adv Cancer Res 2010; 106: 113\u2013164.","journal-title":"Adv Cancer Res"},{"key":"BFonc2017292_CR111","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0022-202X.2004.22243.x","volume":"122","author":"H Tsao","year":"2004","unstructured":"Tsao H, Goel V, Wu H, Yang G, Haluska FG . Genetic interaction between NRAS and BRAF mutations and PTEN\/MMAC1 inactivation in melanoma. J Invest Dermatol 2004; 122: 337\u2013341.","journal-title":"J Invest Dermatol"},{"key":"BFonc2017292_CR112","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","volume":"5","author":"M Jafri","year":"2015","unstructured":"Jafri M, Wake NC, Ascher DB, Pires DE, Gentle D, Morris MR et al. Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma. Cancer Discov 2015; 5: 723\u2013729.","journal-title":"Cancer Discov"},{"key":"BFonc2017292_CR113","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcb.2013.10.002","volume":"93","author":"BB de-Paillerets","year":"2013","unstructured":"de-Paillerets BB, Lesueur F, Bertolotto C . A germline oncogenic MITF mutation and tumor susceptibility. Eur J Cell Biol 2013; 93: 71\u201375.","journal-title":"Eur J Cell Biol"},{"key":"BFonc2017292_CR114","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1083\/jcb.200202049","volume":"158","author":"HR Widlund","year":"2002","unstructured":"Widlund HR, Horstmann MA, Price ER, Cui J, Lessnick SL, Wu M et al. Beta-catenin-induced melanoma growth requires the downstream target microphthalmia-associated transcription factor. J Cell Biol 2002; 158: 1079\u20131087.","journal-title":"J Cell Biol"},{"key":"BFonc2017292_CR115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","volume":"20","author":"WE Damsky","year":"2011","unstructured":"Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE et al. Beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 2011; 20: 741\u2013754.","journal-title":"Cancer Cell"},{"key":"BFonc2017292_CR116","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/biot.200900219","volume":"4","author":"AM Andreou","year":"2009","unstructured":"Andreou AM, Tavernarakis N . SUMOylation and cell signalling. Biotechnol J 2009; 4: 1740\u20131752.","journal-title":"Biotechnol J"},{"key":"BFonc2017292_CR117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/978-1-4419-7002-2_12","volume":"694","author":"AM Andreou","year":"2010","unstructured":"Andreou AM, Tavernarakis N . Roles for SUMO modification during senescence. Adv Exp Med Biol 2010; 694: 160\u2013171.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc2017292_CR118","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc.2016.143","volume":"17","author":"JS Seeler","year":"2017","unstructured":"Seeler JS, Dejean A . SUMO and the robustness of cancer. Nat Rev Cancer 2017; 17: 184\u2013197.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017292_CR119","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1038\/sj.onc.1206450","volume":"22","author":"C Jhappan","year":"2003","unstructured":"Jhappan C, Noonan FP, Merlino G . Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 2003; 22: 3099\u20133112.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4161\/cc.5.12.2810","volume":"5","author":"B Bedogni","year":"2006","unstructured":"Bedogni B, Powell MB . Skin hypoxia: a promoting environmental factor in melanomagenesis. Cell Cycle 2006; 5: 1258\u20131261.","journal-title":"Cell Cycle"},{"key":"BFonc2017292_CR121","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.celrep.2014.05.016","volume":"7","author":"G Bossis","year":"2014","unstructured":"Bossis G, Sarry JE, Kifagi C, Ristic M, Saland E, Vergez F et al. The ROS\/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs. Cell Rep 2014; 7: 1815\u20131823.","journal-title":"Cell Rep"},{"key":"BFonc2017292_CR122","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-319-50044-7_13","volume":"963","author":"LL Scurr","year":"2017","unstructured":"Scurr LL, Haferkamp S, Rizos H . The role of sumoylation in senescence. Adv Exp Med Biol 2017; 963: 215\u2013226.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc2017292_CR123","first-page":"3653","volume":"12","author":"P Lowings","year":"1992","unstructured":"Lowings P, Yavuzer U, Goding CR . Positive and negative elements regulate a melanocyte-specific promoter. Mol Cell Biol 1992; 12: 3653\u20133662.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017292_CR124","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L et al. Pembrolizumab versus Ipilimumab in advanced melanoma. N Engl J Med 2015; 372: 2521\u20132532.","journal-title":"N Engl J Med"},{"key":"BFonc2017292_CR125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tips.2013.10.003","volume":"34","author":"L Tentori","year":"2013","unstructured":"Tentori L, Lacal PM, Graziani G . Challenging resistance mechanisms to therapies for metastatic melanoma. Trends Pharmacol Sci 2013; 34: 656\u2013666.","journal-title":"Trends Pharmacol Sci"},{"key":"BFonc2017292_CR126","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.1212728","volume":"335","author":"JD Kessler","year":"2012","unstructured":"Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 2012; 335: 348\u2013353.","journal-title":"Science"},{"key":"BFonc2017292_CR127","first-page":"E1724","volume":"112","author":"B Yu","year":"2015","unstructured":"Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee CS et al. Oncogenesis driven by the Ras\/Raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci USA 2015; 112: E1724\u2013E1733.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017292_CR128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.csbj.2015.03.001","volume":"13","author":"A Kumar","year":"2015","unstructured":"Kumar A, Zhang KY . Advances in the development of SUMO specific protease (SENP) inhibitors. Comput Struct Biotechnol J 2015; 13: 204\u2013211.","journal-title":"Comput Struct Biotechnol J"},{"key":"BFonc2017292_CR129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","volume":"8","author":"R Zhao","year":"2016","unstructured":"Zhao R, Choi BY, Lee MH, Bode AM, Dong Z . Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in cancer. EBioMedicine 2016; 8: 30\u201339.","journal-title":"EBioMedicine"},{"key":"BFonc2017292_CR130","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1158\/0008-5472.CAN-09-2913","volume":"70","author":"S Giuliano","year":"2010","unstructured":"Giuliano S, Cheli Y, Ohanna M, Bonet C, Beuret L, Bille K et al. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res 2010; 70: 3813\u20133822.","journal-title":"Cancer Res"},{"key":"BFonc2017292_CR131","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1101\/gad.625811","volume":"25","author":"M Ohanna","year":"2011","unstructured":"Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J et al. Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev 2011; 25: 1245\u20131261.","journal-title":"Genes Dev"},{"key":"BFonc2017292_CR132","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/onc.2010.612","volume":"30","author":"T Strub","year":"2011","unstructured":"Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D et al. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 2011; 30: 2319\u20132332.","journal-title":"Oncogene"},{"key":"BFonc2017292_CR133","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(02)00734-1","volume":"109","author":"CA Schmitt","year":"2002","unstructured":"Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109: 335\u2013346.","journal-title":"Cell"},{"key":"BFonc2017292_CR134","first-page":"1876","volume":"62","author":"RH te Poele","year":"2002","unstructured":"te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP . DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62: 1876\u20131883.","journal-title":"Cancer Res"},{"key":"BFonc2017292_CR135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/emmm.201201378","volume":"5","author":"Y Liu","year":"2013","unstructured":"Liu Y, Hawkins OE, Su Y, Vilgelm AE, Sobolik T, Thu YM et al. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-kappaB impairs this drug-induced senescence. EMBO Mol Med 2013; 5: 149\u2013166.","journal-title":"EMBO Mol Med"},{"key":"BFonc2017292_CR136","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656\u2013660.","journal-title":"Nature"},{"key":"BFonc2017292_CR137","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature12437","volume":"501","author":"JR Dorr","year":"2013","unstructured":"Dorr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Dabritz JH et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013; 501: 421\u2013425.","journal-title":"Nature"},{"key":"BFonc2017292_CR138","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1093\/emboj\/cdg417","volume":"22","author":"CM Beausejour","year":"2003","unstructured":"Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22: 4212\u20134222.","journal-title":"EMBO J"},{"key":"BFonc2017292_CR139","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, Campisi J . The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99\u2013118.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2017292_CR140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","volume":"11","author":"F Rodier","year":"2009","unstructured":"Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973\u2013979.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017292_CR141","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133: 1006\u20131018.","journal-title":"Cell"},{"key":"BFonc2017292_CR142","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.18632\/oncotarget.1143","volume":"4","author":"M Ohanna","year":"2013","unstructured":"Ohanna M, Cheli Y, Bonet C, Bonazzi VF, Allegra M, Giuliano S et al. Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype. Oncotarget 2013; 4: 2212\u20132224.","journal-title":"Oncotarget"},{"key":"BFonc2017292_CR143","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR . Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002\u20135011.","journal-title":"Cancer Res"},{"key":"BFonc2017292_CR144","doi-asserted-by":"crossref","first-page":"36396","DOI":"10.1074\/jbc.M111.257071","volume":"286","author":"JP Coppe","year":"2011","unstructured":"Coppe JP, Rodier F, Patil CK, Freund A, Desprez PY, Campisi J . Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem 2011; 286: 36396\u201336403.","journal-title":"J Biol Chem"},{"key":"BFonc2017292_CR145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med 2016; 22: 78\u201383.","journal-title":"Nat Med"},{"key":"BFonc2017292_CR146","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232\u2013236.","journal-title":"Nature"},{"key":"BFonc2017292_CR147","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","volume":"169","author":"MP Baar","year":"2017","unstructured":"Baar MP, Brandt RM, Putavet DA, Klein JD, Derks KW, Bourgeois BR et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 2017; 169: 132\u2013147 e116.","journal-title":"Cell"},{"key":"BFonc2017292_CR148","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exger.2014.10.012","volume":"68","author":"JL Kirkland","year":"2015","unstructured":"Kirkland JL, Tchkonia T . Clinical strategies and animal models for developing senolytic agents. Exp Gerontol 2015; 68: 19\u201325.","journal-title":"Exp Gerontol"},{"key":"BFonc2017292_CR149","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 2015; 14: 644\u2013658.","journal-title":"Aging Cell"},{"key":"BFonc2017292_CR150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 2016; 15: 428\u2013435.","journal-title":"Aging Cell"},{"key":"BFonc2017292_CR151","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jid.2013.6","volume":"133","author":"S Haferkamp","year":"2013","unstructured":"Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhovel S et al. Vemurafenib induces senescence features in melanoma cells. J Invest Dermatol 2013; 133: 1601\u20131609.","journal-title":"J Invest Dermatol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017292","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:05:58Z","timestamp":1647893158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":151,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017,11,30]]}},"alternative-id":["BFonc2017292"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.292","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"21 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}